Literature DB >> 35048827

Electroconvulsive therapy for depression: 80 years of progress.

George Kirov1, Sameer Jauhar2, Pascal Sienaert3, Charles H Kellner4, Declan M McLoughlin5.   

Abstract

Electroconvulsive therapy is the most effective treatment for severe, psychotic or treatment-resistant depression. However, its effectiveness continues to be questioned, both in mainstream media and narratives within the scientific literature. In this analysis, we use an evidence-based approach to demonstrate the efficacy and safety of modern electroconvulsive therapy.

Entities:  

Keywords:  depression; electroconvulsive therapy; evidence-based medicine; meta-analysis; treatment resistance

Mesh:

Year:  2021        PMID: 35048827     DOI: 10.1192/bjp.2021.37

Source DB:  PubMed          Journal:  Br J Psychiatry        ISSN: 0007-1250            Impact factor:   9.319


  4 in total

1.  'Shock tactics', ethics and fear: an academic and personal perspective on the case against electroconvulsive therapy.

Authors:  Tania Gergel
Journal:  Br J Psychiatry       Date:  2022-03       Impact factor: 9.319

Review 2.  A critique of narrative reviews of the evidence-base for ECT in depression.

Authors:  C F Meechan; K R Laws; A H Young; D M McLoughlin; S Jauhar
Journal:  Epidemiol Psychiatr Sci       Date:  2022-01-27       Impact factor: 6.892

3.  A response to yet another defence of ECT in the absence of robust efficacy and safety evidence.

Authors:  John Read
Journal:  Epidemiol Psychiatr Sci       Date:  2022-02-15       Impact factor: 6.892

4.  Dexmedetomidine Regulates the miR-146a-5p/NF-κB Axis to Alleviate Electroconvulsive Therapy-Induced Cognitive Impairments.

Authors:  Xiaohui Zhou; Peipei Si; Li Wang; Huiqun Jia
Journal:  Comput Math Methods Med       Date:  2022-10-04       Impact factor: 2.809

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.